Used in targeted cancer therapy, particularly for solid tumors such as pancreatic, breast, and non-small cell lung cancer. It works by inhibiting the Wnt signaling pathway through binding to multiple Frizzled (FZD) receptors, which are involved in tumor growth and resistance to treatment. By blocking this pathway, it helps suppress tumor progression and can enhance the effectiveness of chemotherapy. Currently investigated in clinical trials to evaluate its safety and efficacy, especially in combination with other anticancer agents.